APA (7th ed.) Citation

Jagomäe, T., Velling, S., Tikva, T. B., Maksimtšuk, V., Gaur, N., Reimets, R., . . . Plaas, M. (2025). GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome. Diabetology & Metabolic Syndrome, 17(1), 1. https://doi.org/10.1186/s13098-025-01651-6

Chicago Style (17th ed.) Citation

Jagomäe, Toomas, Sandra Velling, Tessa Britt Tikva, Varvara Maksimtšuk, Nayana Gaur, Riin Reimets, Allen Kaasik, Eero Vasar, and Mario Plaas. "GABA and GLP-1 Receptor Agonist Combination Therapy Modifies Diabetes and Langerhans Islet Cytoarchitecture in a Rat Model of Wolfram Syndrome." Diabetology & Metabolic Syndrome 17, no. 1 (2025): 1. https://doi.org/10.1186/s13098-025-01651-6.

MLA (9th ed.) Citation

Jagomäe, Toomas, et al. "GABA and GLP-1 Receptor Agonist Combination Therapy Modifies Diabetes and Langerhans Islet Cytoarchitecture in a Rat Model of Wolfram Syndrome." Diabetology & Metabolic Syndrome, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13098-025-01651-6.